Jpmorgan Chase & CO Talis Biomedical Corp Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.81 - $1.44 $5,627 - $10,005	-6,948 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.3 - $4.19 $145,281 - $468,253	-111,755 Reduced 94.15%	6,948 $10,000
Q4 2021 Feb 10, 2022	BUY	$3.81 - $6.17 $135,769 - $219,867	35,635 Added 42.9%	118,703 $476,000
Q3 2021 Nov 12, 2021	BUY	$6.02 - $12.46 $500,069 - $1.04 Million	83,068 New	83,068 $520,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.